Welcome : Guest

BLOOD BANKING AND BLOOD PRODUCTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 209 companies including many key and niche players such as -

AABB
America’s Blood Centers
American Red Cross
Canadian Blood Services
Japan Red Cross Society

Click here to request a full list of companies covered in the report...

Code: MCP-1028
Price: $4950
Companies: 209
Pages: 617
Date: April 2017
Market Data Tables: 165
  Status: * New Report



TABLE OF CONTENTS


  BLOOD BANKING AND BLOOD PRODUCTS (Complete Report) Pages : 617   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Prelude.....II-1
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts.....II-1
1$100
   Safety and Availability: The Core Issues.....II-2 1$100
   Table 1: Prevalence of Major Transfusion- transmitted Infections by Economic Group (2016): Percentage of HIV, HBV and HCV in High Income, Middle Income and Low Income Countries (includes corresponding Graph/Chart).....II-31$350
   Current and Future Analysis.....II-4
Analysis of World Blood Banking & Blood Products by Value Sales.....II-4
Analysis by Geographic Region.....II-4
Analysis by Product Group/Type.....II-4
Plasma and Plasma Derivatives Continue to Dominate Blood Components
  Market.....II-4
1$100
   Equipment, Blood Tests & Other Consumables to Display Steady Growth.....II-51$100
   World Blood Components and Plasma Market Analysis.....II-6 1$100
   Table 2: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-71$350
   Table 3: World 8-Year Perspective for Blood Components and Plasma by Region/ Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart).....II-81$350
   Red Blood Cells – A Key Blood Component.....II-9
Table 4: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-9
1$350
   Table 5: World 8-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2015, 2017 & 2022 (includes corresponding Graph/Chart).....II-101$350
   Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra.....II-11
Table 6: Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenues for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart).....II-11
1$350
   Higher Plasma Center Numbers Key to Secure Raw Material Supply, Costs Remain A
  Bottleneck.....II-12
Table 7: Number of Plasma Centers in Operation in the US for Leading Players (includes corresponding Graph/Chart).....II-12
Platelet Rich Plasma Therapy Market Scales New Heights.....II-12
1$350
   Evolution in Plasma Collection Technologies – Current Achievements and Way
  Ahead.....II-13
1$100
   Demand for Plasma Derivatives on the Rise.....II-141$100
   Immunoglobulins to See Steady Growth.....II-15 1$100
   Table 8: Global Immunoglobulins Market by Segment (2017 & 2022): Percentage Breakdown of Market Value for Intravenous IG, Hyperimmunes and Subcutaneous IG (includes corresponding Graph/Chart).....II-16

Table 9: World IVIG Consumption by Geographic Region (2016): Annual Consumption in Kilograms Per Million People for North America, Europe and Rest of World (includes corresponding Graph/Chart).....II-16
1$350
   Table 10: World Market for Immunoglobulins by Indication (2016): Percentage Breakdown of Market Value for CIPD< PI, Off-Label and Others (includes corresponding Graph/Chart).....II-17
Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market.....II-17
1$350
   Indications Addressed by Major Global IVIg Manufacturers.....II-18
Table 11: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart).....II-18
1$350
   Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg
  Therapy.....II-19
1$100
   Table 12: Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart).....II-201$350
   Unsuccessful Clinical Trials for Alzheimer’s a major Setback for IVIg Market.....II-21
New Indications to Drive Demand for Albumin.....II-21
1$100
   Table 13: World Albumin Consumption by Geography (2016): Annual Consumption in Grams per Thousand People for Leading Ten Countries (includes corresponding Graph/Chart).....II-22
Low Awareness Affects Apha1 Market.....II-22
1$350
   Recombinants Lead FVIII Market.....II-23
Rising Incidence of Cancer Drives Demand for Apheresis Systems.....II-23
1$100
   PrIME: An Innovative High-Yield Process to Address Supply Dearth.....II-24
Present State of Plasma Fractionating Industry.....II-24
1$100
   Plasma Fractionation Industry Concentrated in Developed Countries.....II-25
PrIME Tackles the Issue of Currently Unprocessable Plasma.....II-25
Industry Grappling with Blood Safety & Availability Issues.....II-25
1$100
   New Infections – A Continuous Threat.....II-26
Synthetic Substitutes to Bridge Demand-Supply Gap in Blood.....II-26
1$100
   Autologous Transfusion Gearing up for High Growth.....II-27
Out-of-Hospital Transfusions: An Emerging Phenomenon.....II-27
Automation Tapping into Blood Market.....II-27
1$100
   Automation in Pre-Transfusion Diagnostics.....II-28
Penetration of Automated Equipment in the Plasma Market.....II-28
The Red Blood Cell Collection Opportunity.....II-28
Robots in Blood Banking.....II-28
1$100
   Blood Banks Switching from Manual to Automated Cooler Validation.....II-29
Automated Blood Processing Systems in Open Heart Surgeries.....II-29
Automated Systems in Cancer.....II-29
1$100
   Cerus’ INTERCEPT Blood System Set to See Wider Adoption.....II-301$100
   Pooling: Economical HIV Testing.....II-31
Ballooning Global Geriatric Populace to Drive Demand for Blood Products.....II-31
Table 14: Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart).....II-31
1$350
   Table 15: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart).....II-32
Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector.....II-32
1$350
   Table 16: Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart).....II-331$350
   Table 17: Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart).....II-341$350
   Leaders in Global Blood Plasma Ramp Up Market Share.....II-35
Table 18: Leading Players in the Global Plasma Market (2016): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart).....II-35
Grifols – A Fast Emerging Player.....II-35
1$350
   Table 19: Plasma Fractionation Production Capacity of Grifols by Location: 2011 & 2015 (In Million Liters) (includes corresponding Graph/Chart).....II-36

Table 20: Leading Players in Plasma Fractionation by Capacity (2017 & 2022): Percentage Breakdown of Annual Capacity for CSL, Grifols, Kedrion, Octapharma, Shire and Others (includes corresponding Graph/Chart).....II-36
1$350
   Grifols Loses Grip on IG Market, Pins Hopes on New Product.....II-37
IVIg – A Highly Consolidated Market.....II-37
1$100
   Table 21: Leading Players in the Global Immunoglobulin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart).....II-38

Table 22: Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....II-38
1$350
   Table 23: Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart).....II-39
Big Three Corner Majority of Blood Collection Systems Market.....II-39
1$350
   Table 24: Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart).....II-40

Table 25: Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....II-40
Other Key Statistics.....II-40
Table 26: Leading Players in the Global Albumin Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart).....II-40
1$350
   Table 27: Leading Players in the Global Alpha1 Market (2016E): Percentage Breakdown of Market Value for CSL, Grifols and Others (includes corresponding Graph/Chart).....II-41

Table 28: Leading Players in the Global Plasma Derived FVIII Market (2016E): Percentage Breakdown of Market Value for Biotest, CSL, Grifols, Octapharma, Shire and Others (includes corresponding Graph/Chart).....II-41
1$350
   Blood Banking and Blood Products Industry.....II-42
Blood Components and Plasma Products.....II-42
Equipment, Blood Tests and Consumables.....II-42
Equipment.....II-42
Automated Analyzers for Blood Analysis.....II-42
Blood Collection Equipment.....II-42
1$100
   Blood Collection Monitors.....II-43
Blood Donor Couches.....II-43
Blood Processing Equipment.....II-43
Blood Bank Centrifuges.....II-43
Plasma Thawing.....II-43
Blood Cell Separators.....II-43
Blood Storage Equipment.....II-43
Blood Bags.....II-43
1$100
   Platelet Agitators.....II-44
Blood Bank Refrigerators.....II-44
Blood Tests.....II-44
Consumables.....II-44
Blood – A Primer.....II-44
Ionic Structure.....II-44
1$100
   Blood Components and their Applications.....II-451$100
   Blood Constituents.....II-46
Plasma.....II-46
Red Blood Cells (RBC).....II-46
1$100
   Blood Count.....II-47
Platelets.....II-47
White Blood Cells (WBC).....II-47
Derivative Products of Blood or Plasma Fractions.....II-47
Albumin Fractions.....II-47
1$100
   Immunoglobulins.....II-48
Hyper-Immune Immunoglobulin.....II-48
Factor VIII.....II-48
Factor IX and Factor IX Complex.....II-48
1$100
   Fibrin/Thrombin.....II-49
Consumption of Blood Based on Type of Surgery/Accident (In Units).....II-49
Recombinant Products.....II-49
Blood Plasma Sourcing.....II-49
1$100
   Table 29: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart).....II-50
Plasma Protein and Fractionation.....II-50
Plasma Fractionation: Origins and Development.....II-50
1$350
   Table 30: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics.....II-51
The Need.....II-51
1$350
   Fresh Frozen Plasma.....II-52
Other Plasma Fractions.....II-52
IVIG.....II-52
Factor VIII.....II-52
Albumin.....II-52
1$100
   Therapeutic Uses of Plasma Products.....II-53
Albumin Products.....II-53
Immunoglobulins.....II-53
Intravenous Immunoglobulin (IVIg).....II-53
Normal Immunoglobulin (IMIg).....II-53
CMV Immunoglobulin.....II-53
1$100
   Hepatitis B Immunoglobulin.....II-54
Rh (D) Immunoglobulin.....II-54
Tetanus Immunoglobulin IM.....II-54
Zoster Immunoglobulin.....II-54
Plasma Derived Coagulant Products.....II-54
Biostate®.....II-54
Ceprotin®.....II-54
Factor VII Concentrate.....II-54
1$100
   Factor XI Concentrates.....II-55
Feiba VH® Inhibitor Treatment.....II-55
Fibrogammin P®.....II-55
Monofix®-VF.....II-55
ProthrombinexTM-HT.....II-55
Thrombotrol®-VF.....II-55
1$100
   Banking the Natural Blood Resources.....II-56
Blood Banks.....II-56
Blood Banking.....II-56
Blood Transfusion.....II-56
Role of Blood Banks.....II-56
Blood Donor: The Epicenter of the Process.....II-56
1$100
   Eligibility Criteria for the Donor.....II-57
The Basics of Blood Donation – Myths & Facts.....II-57
1$350
   Table 31: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart).....II-581$350
   Table 32: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart).....II-59
Collection Methods.....II-59
Blood Donation: The Process.....II-59
Types of Blood Donation.....II-59
Directed Blood Donations.....II-59
1$350
   Autologous Blood Donation.....II-60
Alternative Usage of Patient’s Own Blood.....II-60
General Blood Donation.....II-60
Hemodilution.....II-60
Wound Drainage.....II-60
Cell Saver.....II-60
1$100
   The Method.....II-61
Blood Salvaging.....II-61
Blood Collection Centers.....II-61
Blood Collection Management System.....II-61
A Historical Retrospective.....II-61
Blood Collection Centers.....II-61
1$100
   Types of Blood Collection Centers.....II-62
Cord Blood Banks.....II-62
Profit Collection Centers.....II-62
Military Blood Banks.....II-62
Hospital Blood Banks.....II-62
1$100
   Community Blood Banks.....II-63
Non-Profit Collection Centers.....II-63
Blood Processing.....II-63
1$100
   Blood Typing.....II-64
Rh Blood Group System.....II-64
ABO Blood Group System.....II-64
1$100
   Blood Types and their Compatibility.....II-65
Table 33: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart).....II-65
Blood Test.....II-65
1$350
   Blood Culture.....II-66
The Costs.....II-66
History of Blood Banking.....II-66
3$300
   Blood Transfusion: A Backdrop.....II-69
Massive Transfusion.....II-69
Complications and Risks Due to Transfusion.....II-69
1$100
   Circulatory Overload.....II-70
Graft Versus Host Disease (GVHD).....II-70
Hemolytic Transfusion Reactions.....II-70
Iron Overload.....II-70
Bacterial Contamination.....II-70
Thrombophlebitis.....II-70
Allergic Reactions.....II-70
1$100
   Air Embolism.....II-71
Hyperkalaemia.....II-71
Changing Role of Blood Banking Technology.....II-71
1$100
   Cross Matching.....II-72
Blood Donor/Recipient Screening.....II-72
Blood Typing.....II-72
Leukoreduction.....II-72
1$100
   Leukocyte Reduction Specification Standards/Filters.....II-73
Coombs Test.....II-73
1$100
   Bloodless Surgery.....II-74
Therapeutic Apheresis.....II-74
Plasmapheresis.....II-74
Plateletpheresis.....II-74
1$100
   Leukapheresis.....II-75
Volume Expanders.....II-75
Colloids.....II-75
Albumin.....II-75
Dextrans.....II-75
Hydroxyethyl Starch.....II-75
Crystalloids.....II-75
1$100
   Blood Growth Factor Therapies – Newer Alternatives to Transfusion.....II-761$100
   Biotest Secures EC Clearance for Vihuma.....II-77
Roche Launches cobas m 511 Haematology Analyser.....II-77
Abbott Obtains CE Mark for Alinity™ s Blood and Plasma Screening Device.....II-77
Bio-Rad Secures FDA Clearance for New Blood Typing Instrument and Regents.....II-77
Immucor Gets CE Mark for NEO Iris™ Automated Transfusion Instrument.....II-77
Immucor’s PreciseType® HEA Test Obtains FDA Approval.....II-77
1$100
   Fresenius Kabi Obtains FDA Approval for Aurora™ Xi Plasmapheresis System.....II-78
BD Secures FDA Clearance for BD Barricor Plasma Blood Collection Tube.....II-78
Cerus Gains Health Canada’s Approval for INTERCEPT System.....II-78
FDA Clears BD’s New Plastic Blood Culture Bottle.....II-78
FDA Approves Cerus’ INTERCEPT Blood System.....II-78
BD Obtains CE Mark for Vacutainer® Barricor™ Tube.....II-78
BD Secures FDA and EU Clearance for BD Vacutainer® UltraTouch™ Blood Collection
  Set.....II-78
1$100
   Roche Expands Blood Screening Solution Portfolio with New Offering.....II-79
Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2.0 for HIV, HCV, and
  HBV Tests.....II-79
Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient
  Plasmas.....II-79
1$100
   Biotest to Sell Select US Therapy Business Assets to ADMA.....II-80
Kedrion Biopharma Expands into Russia.....II-80
Hologic to Sell Blood Screening Business to Grifols.....II-80
China Biologic Products Gets CFDA Clearance for Antithrombin III Clinical
  Trial.....II-80
China Biologic Receives CFDA Clearance for Human Trials on Human Coagulation Factor
  IX.....II-80
1$100
   Terumo Inks Distribution Agreement with B Medical Systems.....II-81
Creat Group Takes Over Bio Products.....II-81
Terumo Receives Initial Funding for FDP Product from US Government.....II-81
Shire Takes Over Baxalta.....II-81
LFB American Plasma and ImmunoTek BioCenters Ink Agreement.....II-81
Grifols Expands Plasma Therapies’ Production Capacity.....II-81
KEDPlasma Acquires Two Plasma Collection Centers in the US.....II-81
1$100
   Cerus and LifeShare Blood Centers Ink Purchase Agreement for INTERCEPT.....II-82
Cerus Inks Production Deal with Fresenius Kabi for INTERCEPT Blood System.....II-82
Baxter Spins Off Biopharmaceutical Business into Baxalta (US).....II-82
Cerus and SunCoast Blood Bank Ink Deal for INTERCEPT Blood System.....II-82
Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital.....II-82
Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva.....II-82
Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile
  Program.....II-82
1$100
   Roche Releases Elecsys HTLV-I/II Immunoassay.....II-83
China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological
  Products.....II-83
Community Blood Center Merges with New York Blood Center.....II-83
Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets
  Kits.....II-83
Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating
  Hemorrhage.....II-83
The San Diego Blood Bank Collaborates with Clinical and Translational Research
  Institute.....II-83
1$100
   AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in
  Asia.....II-84
bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and
  New Zealand.....II-84
PrIME Biologics Opens Plasma Fractionation Plant in Singapore.....II-84
1$100
   Leading Blood Banks.....II-85
AABB (USA).....II-85
America’s Blood Centers (USA).....II-85
1$100
   American Red Cross (USA).....II-86
Canadian Blood Services (Canada).....II-86
Japan Red Cross Society (Japan).....II-86
1$100
   New York Blood Center (USA).....II-87
Sanquin Blood Supply Foundation (The Netherlands).....II-87
Leading Players in Blood Bank Technology and Supplies.....II-87
Abbott Laboratories (USA).....II-87
1$100
   Beckman Coulter, Inc. (USA).....II-881$100
   Becton, Dickinson and Company (USA).....II-89
bioMérieux SA (France).....II-89
1$100
   Bio-Rad Laboratories, Inc. (USA).....II-90
Cerus Corporation (USA).....II-90
1$100
   CSL Behring LLC (USA).....II-91
Fresenius Kabi AG (Germany).....II-91
1$100
   Fenwal Inc. (USA).....II-92
Haemonetics Corporation (USA).....II-92
1$100
   Immucor Inc. (USA).....II-93
Kawasumi Laboratories, Inc. (Japan).....II-93
1$100
   MacoPharma SA (France).....II-94
Ortho-Clinical Diagnostics, Inc. (USA).....II-94
1$100
   Terumo BCT Inc. (USA).....II-95
Leading Players in Plasma Fractionation.....II-95
Beijing Tiantan Biological Products Co., Ltd. (China).....II-95
1$100
   Bharat Serums and Vaccines Ltd. (India).....II-96
Bio Products Laboratory Ltd. (UK).....II-96
Biotest AG (Germany).....II-96
1$100
   China Biologic Products, Inc. (China).....II-97
Grifols S.A. (Spain).....II-97
1$100
   Huanlan Biological Engineering Inc. (China).....II-98
Kedrion S.p.A. (Italy).....II-98
1$100
   LFB Group (France).....II-99
Octapharma AG (Switzerland).....II-99
Shanghai RAAS Blood Products Co., Ltd. (China).....II-99
1$100
   Shire plc (Ireland).....II-100
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China).....II-100
1$100
   Table 34: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1011$350
   Table 35: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1021$350
   Table 36: World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1031$350
   Blood Banking and Blood Products Market by Product Group/Type.....II-104
Table 37: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-104
1$350
   Table 38: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1051$350
   Table 39: World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1061$350
   Table 40: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1071$350
   Table 41: World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1081$350
   Table 42: World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1091$350
   Table 43: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1101$350
   Table 44: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1111$350
   Table 45: World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1121$350
   Table 46: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1131$350
   Table 47: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1141$350
   Table 48: World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1151$350
   Table 49: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-1161$350
   Table 50: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-1171$350
   Table 51: World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-1181$350
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Demand for Blood Transfusion Wanes.....III-1
1$75
   Table 52: US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart).....III-21$200
   Table 53: US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart).....III-3

Table 54: American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart).....III-3
Blood Collection Economy Treads a Tightrope.....III-3
1$200
   Lower Blood Prices Become the Order of the Day.....III-4
Aging Baby-Boomer Demography: A Key Market Driver.....III-4
1$75
   Table 55: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-5
Favorable Reimbursement and High Usage Make US the Largest Consumer of
  Immunoglobulins Worldwide.....III-5
US Blood Collection & Supply Profile.....III-5
1$200
   Table 56: Number of Plasma Collection Centers in the US: 2011-2015 (includes corresponding Graph/Chart).....III-6

Table 57: US Plasma Collections for Years 2009, 2012 & 2015 (In Millions) (includes corresponding Graph/Chart).....III-6
Blood Group Distribution.....III-6
1$200
   Table 58: US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart).....III-7

Table 59: Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart).....III-7
1$200
   US Plasma Industry Remains Highly Concentrated.....III-8
Table 60: US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart).....III-8
Tough Times Ahead for IVIG.....III-8
1$200
   Approved and Marketed Human Immunoglobulin Products in the US.....III-91$75
   Key Statistics.....III-10
Table 61: US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart).....III-10

Table 62: US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL, Grifols, and Others (includes corresponding Graph/Chart).....III-10
1$200
   Table 63: US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....III-11

Table 64: US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart).....III-11
1$200
   Table 65: US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart).....III-12

Table 66: US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart).....III-12
Changing Supply Dynamics Alters Economics of Plasma Production.....III-12
1$200
   Table 67: Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart).....III-131$200
   Regulations Control Plasma Collection Industry.....III-14
Key Statistics.....III-14
Table 68: US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....III-14

Table 69: US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart).....III-14
1$200
   Table 70: US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart).....III-15
Product Approvals/Launches.....III-15
1$200
   Strategic Corporate Developments.....III-162$150
   Select Key Players.....III-189$675
   B. Market Analytics.....III-27
US Blood Components and Plasma Market Analyzed by Value Sales.....III-27
Table 71: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-27
1$200
   Table 72: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-281$200
   Table 73: US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-291$200
   US Blood Components and Plasma Market Analyzed by Consumption in Units.....III-30
Table 74: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-30
1$200
   Table 75: US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-311$200
   Table 76: US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-321$200
   A. Market Analysis.....III-33
Current and Future Analysis.....III-33
Canada Continues to Rely on Imports to Meet Demand for Blood Plasma.....III-33
Bleeding Disorders – A Major Threat.....III-33
'CSA-Z902-04' – A Comprehensive Voluntary Blood Safety Standard.....III-33
1$75
   Product Launches/Approvals.....III-34
Strategic Corporate Developments.....III-34
Canadian Blood Services – The Major Blood Bank.....III-34
1$75
   B. Market Analytics.....III-35
Table 77: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-35
1$200
   Table 78: Canadian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-361$200
   Table 79: Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-371$200
   A. Market Analysis.....III-38
Current and Future Analysis.....III-38
Japan Witnesses Surge in Imported Blood Products.....III-38
Growing Market for Fresh Frozen Plasma.....III-38
Growing Use of Imported Albumin Based Blood Products.....III-38
1$75
   The Goal of Self-Sufficiency.....III-39
Graying Population to Drive Market Growth.....III-39
1$75
   Table 80: Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart).....III-40
Strategic Corporate Development.....III-40
1$200
   Select Players.....III-411$75
   B. Market Analytics.....III-42
Table 81: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-42
1$200
   Table 82: Japanese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-431$200
   Table 83: Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Current and Future Analysis.....III-45
Market Trends and Issues.....III-45
Legislations on Payment for Donation Restrict Donors.....III-45
Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers.....III-45
Purchasing System Witnesses Modifications.....III-45
1$75
   Aging Population to Drive Demand for IVIg Products.....III-46
Table 84: Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart).....III-46
1$200
   Table 85: European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart).....III-47
Overview of Blood Banking Market.....III-47
Competitive Scenario.....III-47
Alpha 1 Market to Benefit from Growing Competition.....III-47
1$200
   Key Statistics.....III-48
Table 86: European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart).....III-48

Table 87: European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....III-48
1$200
   Challenges Exist in EU Blood and Blood Components Supply.....III-49
Product Approvals.....III-49
1$75
   B. Market Analytics.....III-50
Table 88: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-50
1$200
   Table 89: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-511$200
   Table 90: European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-521$200
   Table 91: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-531$200
   Table 92: European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-541$200
   Table 93: European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-551$200
   Table 94: European Recent Past, Current & Future Analysis for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-561$200
   Table 95: European Historic Review for Blood Collection Devices by Type - Manual Blood Collection, Apheresis and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-571$200
   Table 96: European 14-Year Perspective for Blood Collection Devices by Type - Percentage Breakdown of Value Sales for Manual Blood Collection, Apheresis and Autologous Devices Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-581$200
   A. Market Analysis.....III-59
Current and Future Analysis.....III-59
Blood Collection and Transfusion Operations in France – An Overview.....III-59
Strategic Corporate Development.....III-59
Key Players.....III-59
2$150
   B. Market Analytics.....III-61
Table 97: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-61
1$200
   Table 98: French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-621$200
   Table 99: French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-631$200
   A. Market Analysis.....III-64
Current and Future Analysis.....III-64
A Peek into German Blood Transfusion Organizational Set Up.....III-64
Product Approvals/Launches.....III-64
1$75
   Select Players.....III-651$75
   B. Market Analytics.....III-66
Table 100: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-66
1$200
   Table 101: German Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-671$200
   Table 102: German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-681$200
   A. Market Analysis.....III-69
Current and Future Analysis.....III-69
Blood Transfusion Operational Structure in Italy – An Overview.....III-69
Kedrion S.p.A. – A Leading Italian Player for Plasma Fractionation.....III-69
1$75
   B. Market Analytics.....III-70
Table 103: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-70
1$200
   Table 104: Italian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-711$200
   Table 105: Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-721$200
   A. Market Analysis.....III-73
Current and Future Analysis.....III-73
A Peek into UK Blood Transfusion Operations.....III-73
Strategic Corporate Development.....III-73
Bio Products Laboratory Ltd – A Leading UK Player for Plasma Fractionation.....III-73
1$75
   B. Market Analytics.....III-74
Table 106: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-74
1$200
   Table 107: UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-751$200
   Table 108: UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-761$200
   A. Market Analysis.....III-77
Current and Future Analysis.....III-77
Blood Transfusion in Spain.....III-77
Strategic Corporate Development.....III-77
Grifols, S.A – A Leading Spanish Player for Plasma Fractionation.....III-77
2$150
   B. Market Analytics.....III-79
Table 109: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-79
1$200
   Table 110: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-801$200
   Table 111: Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-811$200
   A. Market Analysis.....III-82
Current and Future Analysis.....III-82
Strategic Corporate Development.....III-82
1$75
   B. Market Analytics.....III-83
Table 112: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-83
1$200
   Table 113: Russian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-841$200
   Table 114: Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-851$200
   A. Market Analysis.....III-86
Current and Future Analysis.....III-86
Product Launches.....III-86
Strategic Corporate Developments.....III-86
1$75
   Select Players.....III-871$75
   B. Market Analytics.....III-88
Table 115: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-88
1$200
   Table 116: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-891$200
   Table 117: Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-901$200
   A. Market Analysis.....III-91
Current and Future Analysis.....III-91
ASEAN – Striding Towards Standardization of Blood Supply.....III-91
1$75
   B. Market Analytics.....III-92
Table 118: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-92
1$200
   Table 119: Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-931$200
   Table 120: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-941$200
   Table 121: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-951$200
   Table 122: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-961$200
   Table 123: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-971$200
   A. Market Analysis.....III-98
A Key Market.....III-98
Government Wakes Up to Realities.....III-98
1$75
   Table 124: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart).....III-99

Table 125: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart).....III-99

Table 126: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart).....III-99
1$200
   Overview of Chinese Blood Plasma Market.....III-1001$75
   Availability of Plasma Proteins in the US and China (2015): A Comparison.....III-101 1$75
   Table 127: Chinese Plasma Products Market by Product Type (2015): Percentage Breakdown of Value Sales for Albumin, Hyper-immune, IVIg and Others (includes corresponding Graph/Chart).....III-102
Government Exercises Strict Control Over Production, Supply and Import of
  Plasma-based Products.....III-102
1$200
   Gap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing
  Output.....III-103
1$75
   Table 128: Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2015 (includes corresponding Graph/Chart).....III-1041$200
   Table 129: Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2015 (includes corresponding Graph/Chart).....III-105
Comparison of Average Yields for Select Plasma Based Products in China and
  International Markets.....III-105
Deregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based
  Products.....III-105
1$200
   Expanding Medical Indications Holds Key to Boosting Market Growth.....III-106
Comparison of USFDA and CFDA Approved Indications for Human Albumin Therapeutic
  Products.....III-106
1$75
   Comparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic
  Products.....III-107
Competitive Landscape.....III-107
Table 130: Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-107
1$200
   Blood Plasma Product Portfolio of Major Domestic Players.....III-108 1$75
   Table 131: Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart).....III-109
Albumin Market in China Gains Favor of both Global and Local Players.....III-109
1$200
   Table 132: Leading Players in the Chinese Albumin Market (2016): Percentage Breakdown of Approvals for Baxalta, CSL, Grifols and Others (includes corresponding Graph/Chart).....III-110
IVIG – Strong Opportunities Ahead.....III-110
Domestic Players Rule IVIG Market.....III-110
1$200
   Table 133: Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2016): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-111
Plasma Derived Factor VIII – Nascent but Hold Potential.....III-111
Table 134: Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart).....III-111
1$200
   Other Key Statistics.....III-112
Table 135: Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart).....III-112
1$200
   Table 136: Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-1131$200
   Table 137: Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological , Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-114

Table 138: Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart).....III-114
1$200
   Table 139: Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart).....III-115

Table 140: Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-115
1$200
   Table 141: Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart).....III-116

Table 142: Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart).....III-116
1$200
   Table 143: Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart).....III-117
Strategic Corporate Developments.....III-117
1$200
   Select Key Players.....III-1182$150
   B. Market Analytics.....III-120
Table 144: Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-120
1$200
   Table 145: Chinese Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1211$200
   Table 146: Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1221$200
   A. Market Analysis.....III-123
Current and Future Analysis.....III-123
Plasma Fractionation in Southeast Asia – A Focus on Current and Planned
  Capabilities.....III-123
1$75
   Overview of Select Regional Markets.....III-124
Australia.....III-124
National Blood Supply: An Overview.....III-124
Role of National Blood Authority.....III-124
Maintenance Expenditure on the Rise.....III-124
1$75
   Red Blood Cells Demand Shows Mixed Fortunes.....III-125
India.....III-125
Demand for Blood Banking Equipment Market on the Rise.....III-125
1$75
   Recent Trends in the Market.....III-126
Indian Blood Banking Market Witnesses Major Transformations.....III-126
1$75
   Market Growth – Influencing Factors.....III-127
Increased Awareness Drives Voluntary Blood Donations in India.....III-127
Competitive Scenario.....III-127
1$75
   Indonesia.....III-128
Korea.....III-128
Increasing Overseas Opportunities for Korean Blood Plasma Products.....III-128
1$75
   Strategic Corporate Developments.....III-129
Bharat Serums And Vaccines Ltd. – A Leading Indian Player for Plasma
  Fractionation.....III-129
1$75
   B. Market Analytics.....III-130
Table 147: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-130
1$200
   Table 148: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1311$200
   Table 149: Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1321$200
   A. Market Analysis.....III-133
Current and Future Analysis.....III-133
Table 150: Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart).....III-133
1$200
   B. Market Analytics.....III-134
Table 151: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-134
1$200
   Table 152: Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1351$200
   Table 153: Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1361$200
   Table 154: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-1371$200
   Table 155: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1381$200
   Table 156: Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1391$200
   Market Analysis.....III-140
Table 157: Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-140
1$200
   Table 158: Brazilian Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1411$200
   Table 159: Brazilian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1421$200
   Market Analysis.....III-143
Table 160: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-143
1$200
   Table 161: Rest of Latin America Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1441$200
   Table 162: Rest of Latin America 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1451$200
   A. Market Analysis.....III-146
Current and Future Analysis.....III-146
B. Market Analytics.....III-146
Table 163: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-146
1$200
   Table 164: Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1471$200
   Table 165: Rest of World 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-1481$200
  
Total Companies Profiled: 209 (including Divisions/Subsidiaries - 253)

Region/Country Players

The United States 117 Canada 10 Japan 12 Europe 51 France 4 Germany 13 The United Kingdom 11 Italy 4 Spain 3 Rest of Europe 16 Asia-Pacific (Excluding Japan) 59 Middle East 1 Latin America 1 Africa 2
Click here to request a full table of contents and more details on this project.